Legato Capital Management LLC has filed a Form 13F-HR with the U.S. Securities and Exchange Commission, disclosing its equity holdings as of September 30, 2026. The filing, signed by President, CEO, and Chief Compliance Officer Victor L. Hymes on November 6, 2026, lists a total of 674 distinct equity positions held by the firm.
The report indicates that the firm's portfolio is diversified across a wide range of sectors, including technology, healthcare, financial services, and consumer goods. Notable holdings mentioned in the filing include Apple Inc., Amazon.com Inc., Alphabet Inc. Class A and Class C, Microsoft Corporation, and Visa Inc. The portfolio also includes positions in biotechnology companies such as Eli Lilly and Company and Amgen Inc., as well as financial institutions like JPMorgan Chase & Co. and Bank of America Corp.
The filing provides a comprehensive list of all equity securities held by Legato Capital Management, detailing the number of shares for each position. The report serves as a public record of the firm's investment activities and is required to be filed quarterly by investment managers with assets exceeding $100 million.
